Sleep and Morning Wellbeing Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-59
SponsorAthletic Greens International
About this trial
The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male or female.
Age 25-59 years.
BMI ≥18.5 and ≤29.9 kg/m².
Currently experiencing issues with sleep quality, falling asleep, staying asleep, or waking during the night.
Disqualifiers
Diagnosed chronic sleep conditions (e.g., insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, sleep apnea).
Current use of sleep-tracking technology (e.g., wrist-worn trackers, rings, smartphone apps) that could influence sleep behavior or perception.
Use of hormone therapy (estrogen, progesterone, phytoestrogens) within the last 3 months.
Diagnosed psychiatric disorders including major depressive disorder with acute symptoms, bipolar disorder, generalized anxiety disorder with active symptoms, and PTSD with frequent nightmares.
Trial design
Design model
Parallel
Treatments tested in this trial
Sleep Supplement
Dietary supplementPowdered sleep supplement
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: Sleep SupplementExperimental treatment 1 intervention
Group B: Usual DietNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Evening relaxation, sleep quality, and morning vitality
Assessed by subjective questionnaire
Time frame
Days 1, 3, 7, 14, 30Other outcomes
1
Sleep quality
Assessed by subjective questionnaire
Time frame
Days 7, 14, and 302
Daytime Sleepiness
Assessed by subjective questionnaire
Time frame
Days 1, 7, 14, and 30Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov